The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×

To the Editor: Drs. Pilowsky and Ell claim that clozapine treatment induces regionally selective occupancy of D2 receptors in vivo. In our study we did not find support for regional selectivity. We agree with Drs. Pilowsky and Ell that this issue needs to be clarified.

Using the high-affinity PET radioligand [11C]FLB 457, a close analog of the SPECT ligand [123I]epidepride, we were initially puzzled by images that gave the impression of higher occupancy in extrastriatal regions. This unexpected observation was made for patients treated with clozapine and patients treated with low doses of haloperidol and seemed to be confirmed when ratio analyses were applied for the calculation of D2 occupancy. However, this finding was not confirmed when we used [11C]raclopride for striatal binding. We recently conducted a study that suggests methods limitations as a possible reason for the discrepant results (1).

When ratio approaches are used to obtain reliable estimates for binding potential, the radioactivity must reach equilibrium during the acquisition time. The problem is that the time to reach equilibrium is highly dependent on the density of D2 receptors, which varies about 100-fold in the human brain. A consequence is that regions with low receptor density (i.e., the temporal cortex) will reach equilibrium long before regions with high receptor density (i.e., the striatum). As shown in simulations based on experimental data, the end-time method, a ratio method used in SPECT, overestimates the binding potential if the time to equilibrium is within the time of data acquisition but underestimates the binding potential if the time to equilibrium falls beyond the acquisition time (1). In SPECT studies using this method, low striatal and high extrastriatal binding potential have been reported (2, 3). In the reports of the PET studies referred to in the letter, the methods were not reported in detail, which makes it difficult to appraise the results (Meltzer et al., 1999; Xiberas et al., 1999). It cannot be discounted that these results were also influenced by the methods limitations of applying a ratio analysis on striatal binding at pre-equilibrium conditions.

References

1. Olsson H, Farde L: Potentials and pitfalls using high affinity radioligands in PET and SPET determinations on regional drug induced D2 receptor occupancy—a simulation study based on experimental data. Neuroimage 2001; 14:936-945Crossref, MedlineGoogle Scholar

2. Pilowsky LS, Mulligan RS, Acton PD, Ell PJ, Costa DC, Kerwin RW: Limbic selectivity of clozapine (letter). Lancet 1997; 350:490-491Crossref, MedlineGoogle Scholar

3. Bigliani V, Mulligan RS, Acton PD, Ohlsen RI, Pike VW, Ell PJ, Gacinovic S, Kerwin RW, Pilowsky LS: Striatal and temporal cortical D2/D3 receptor occupancy by olanzapine and sertindole in vivo: a [123I]epidepride single photon emission tomography (SPET) study. Psychopharmacology (Berl) 2000; 150:132-140Crossref, MedlineGoogle Scholar